Consistent Execution with a Long-term View
Consistent History of Strong Growth and Profitability
Revenue
Non-GAAP Operating Income¹
$862M
$691M
$551M
FY172
$173M
FY182
$220M
FY19
$1.10B
$1.47B
$1.85B
$2.145B
$820M
$759M
$583M
$412M
$307M
FY203
FY213
FY22
FY23E4
Fiscal Year Ending January 31
1 A reconciliation of GAAP to non-GAAP measures is set forth in the Appendix
2 Restated for ASC 606
3 The Crossix and Physicians World acquisitions closed in the quarter ended January 31, 2020 and contributed an aggregate of $20M in total revenue for the year ended January 31, 2020 and $103M for the year ended January 31, 2021.
4 Based on the high end of our guidance issued August 31, 2022. We are not able, at this time, to provide GAAP targets for operating income for the fiscal year ending January 31, 2023 because of the difficulty of estimating certain items excluded from non-GAAP
operating income that cannot be reasonably predicted, such as charges related to stock-based compensation expense. The effect of these excluded items may be significant.
Copyright Veeva Systems 2022View entire presentation